APYX Stock Analysis: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$3.97
-0.42 (-9.57%)
▼
5d:
-1.0%
30d:
+12.15%
90d:
+24.06%
BUY
HIGH Confidence
Analysis Updated: Feb 4, 2026 12:00 AM ET
Earnings: Mar 12, 2026
Smart Money Distribution
APYX is up 4.8% this week, but smart money is buying puts. Top strike: $2.5 2026-03-20 with 761 OI. Put ratio: 98% View Scanner →
Strength: 7.2/10
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: APYX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: APYX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $3.97, which is considered fair relative to its 30-day fair value range of $3.55 to $4.11.
Technical Outlook: Technically, APYX is in a strong uptrend. Immediate support is located at $3.76, while resistance sits at $4.50. Short-term momentum is weak, with the stock down 9.6% recently.
Market Sentiment: APYX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.00 (+36.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APYX is in a strong uptrend. Immediate support is located at $3.76, while resistance sits at $4.50. Short-term momentum is weak, with the stock down 9.6% recently.
Market Sentiment: APYX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $6.00 (+36.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.55 -
$4.11
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
85.4%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.6%)
- BULLISH: Trading 36.7% below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$3.55 -
$4.11
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.50
(12.6%)
Support & Resistance Levels
Support Level
$3.76
Resistance Level
$4.50
Current Trend
Strong Uptrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.80
Wall Street Target
$6.00
(+36.7%)
Revenue Growth (YoY)
12.1%
Profit Margin
-30.3%
Last updated: February 04, 2026 2:26 PM ET
Data refreshes hourly during market hours. Next update: 3:26 PM
Data refreshes hourly during market hours. Next update: 3:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 41 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 53 HOLD |
